Present, Diligent evaluate and assess complex reports from clinical development projects aswell as post marketing cases.Reporting sources include medical literature as well as, clinical trials and post-marketingsurveillance studies; Ensure high medical quality and compliance with all health authorityrequirements regarding AE/ADR single case handling;Confirm determination of seriousness, assess drug product causal association and globallabeling status (expected or unexpected) in order to achieve the appropriate case reportingstatus for global distribution for regulatory agency reporting;Provide medical/clinical advice for non-medic group members; Be informed of the presentcoding systems (MedDRA and WHO- DD) with respect to structure and medical content;Identify critical case reports that require immediate attention of the Global Safety Leader(GSL), including cases that are potentially suitable for extended discussion in PV aggregatereports (PBRER/ PSURs, DSUR and ASRs).